|
USTR was created to consolidate in one affordable professional service center the many resources required to support its clients emerging medical technology needs.
USTR never loses sight that our client's goal is increased sales and profits.
At the time R&D starts a strategy should be in place with an objective towards maximizing revenue potential. Every clinical study should be structured to satisfy not only the FDA but also sales and reimbursement decision makers your product faces after the FDA approval is obtained.
The medical device market requires an integrated regulatory, sales and reimbursement effort. Many companies have neither the resources nor expertise to effectively execute those regulatory, sales and reimbursement activities required to bring their product to market. USTR will perform those functions that are currently overextending a company or facility resources or those functions that require a higher level of expertise than currently exists.
USTR provides those specialized services to take full advantage of opportunities to expand your markets at a fraction of the cost of adding full time specialists to your payroll.
USTR as your outsource regulatory, sales and reimbursement department is a focused team to increase awareness and utilization. We customize our team dependent upon where the medical device is on the product development lifecycle and what your particular regulatory, sales and reimbursement needs may be.
Our expertise in assessing how regulatory, sales and reimbursement will affect market share and return on investment provide you and your investors with recommendations you need to make correct decisions.
We invite you to examine the unique services we offer and to consider their value to your own product development marketing activities.
|
